GM Tobacco Expressing Cervical Cancer VaccineMay 16, 2008
Cervical cancer is one of the most common cancers in developing countries and the second most prevalent cancer in women. Almost all cervical cancers result from human papillomavirus (HPV) infection. Although vaccines against the virus, based on virus-like particles rather on attenuated HPV, have recently been made available, their high cost prohibits their widespread use especially in developing countries.
In search of ways that will make HPV vaccine production cheaper, scientists from Spain and France developed transgenic tobacco lines expressing the HPV protein L1. L1 is a major structural protein in the viral capsid (protein shell) that aggregates to form non-infectious virus-like particles (VLP). Since it can induce both humoral and cellular responses, VLPs are prime candidates in the production of HPV vaccines.
The viral gene coding for L1 was specifically expressed in the chloroplasts. Chloroplast transformation offers several advantages such as transgene containment, absence of gene silencing and high recombinant protein yield. High L1 expression, equivalent to 24 percent of the total soluble protein, was achieved in mature GM plants. Immunization experiments have shown that the recombinant protein and the resulting VLPs are highly immunogenic.
The article published by the Plant Biotechnology Journal is available at http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-7652.2008.00338.x
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- FAO Sees Strong Signs of Record Rice Production
- UN Conference Discusses Liability Rules and Redress
- New Ideas to Boost World Tea Market
- Uganda Puts Up Biotech Center for Cassava
- ARS Releases Nematode, Virus Resistant Peanut Variety
- GE Approaches to Improve Nitrogen Use Efficiency
- DuPont and Genencor Form Cellulosic Ethanol Venture
- Taiwan Implements Stacks Registration
- ABARE Report : Australia to Benefit from GM Crops
- Pakistan Environment Minister Calls for GMOs in Agriculture
- Agricultural Scientists in Pakistan Urged to Develop Biotech Varieties
- Bayer Launches Disease Resistant Rice
- ICRISAT: Sweet Sorghum Could be the Miracle Biofuel Crop
- DEFRA Approves GM Potato Trial
- PRRI Open Letter to EC Members
- German Ag-Industries Say EU Biotech Policy Affecting Supply Problem
- Plant Bioscience Enters Licensing Agreement
- Starch Degrading Enzyme from GM Potatoes
- GM Tobacco Expressing Cervical Cancer Vaccine
- Brassinosteroids and Water Stress Response
- CropLife International Online Database on Agri-biotech Benefits
Subscribe to CBU: